| |
New and Emerging ALK/ROS1/NTRK-Targeted Agents in NSCLC: Addressing Treatment Resistance and CNS Metastases |
, , , , , |
|
On-Demand Webcast |
| |
Immunotherapy-Based Combination Therapies in NSCLC: Addressing Treatment Resistance |
, , , , |
|
On-Demand Webcast |
| |
Novel Treatment Options for Metastatic NSCLC: A Focus on EGFR and MET Alterations and Strategies to Combat Adverse Events |
, , , , , |
|
On-Demand Webcast |
| |
Intravenous Iron in Inflammatory Bowel Disease: Closing Outcomes Chasms through the Effective Management of Iron Deficiency Anemia |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
Evolving Strategies for the Management of Recurrent C. difficile Infection in Patients with IBD |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
Selective Sphingosine 1-Phosphate Receptor Modulators and Other Patient-Care Opportunities in IBD |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
The Current and Potential Role of IL-12/23 and IL-23 Inhibition in Data-Driven Management of IBD |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
Evolving Considerations for Therapeutic Drug Monitoring in IBD: Who, What, Why, When, and How? |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
Assessing the Evolving Role of Anti-TNF Biosimilars in Inflammatory Bowel Disease: Rationale and Considerations for Management |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
| |
Identifying and Managing Bowel Urgency in Ulcerative Colitis |
, , , , , |
Gastroenterology, Immunology |
On-Demand Webcast |
